News & Perspective

Jan 11, 2011

Jan 11, 2011

Expert says US should agree to destroy smallpox virus stocks

(CIDRAP News) – Given the potential for a bitter diplomatic battle at the World Health Assembly (WHA) in May, an expert on smallpox-related policy is recommending that the United States agree to the destruction of the remaining stocks of smallpox virus—or at least be prepared to destroy all but a remnant of them.

Feb 11, 2011

Feb 11, 2011

Study showing high effectiveness for H1N1 vaccine stirs debate

(CIDRAP News) – A recent case-control study estimates that the adjuvanted pandemic H1N1 influenza vaccine used in Canada was effective 93% of the time, a substantially higher figure than seen in several other studies and one that has raised some eyebrows among other flu vaccine researchers.

Feb 21, 2011

Feb 21, 2011

Flu activity shows signs of receding in Europe

(CIDRAP News) – Influenza activity persists at medium to high levels in most European Union countries but is showing signs of decreasing, according to the latest report from the European Centre for Disease Prevention and Control (ECDC).

Feb 24, 2011

Feb 24, 2011

FDA approves preliminary test for norovirus

(CIDRAP News) – The US Food and Drug Administration (FDA) has announced approval of what it calls the first test for preliminary identification of norovirus, intended for use in outbreaks in which there is a likely transmission pathway.

Apr 08, 2011

Apr 08, 2011

Measles outbreaks prompt travel and vaccine advisories

(CIDRAP News) – Measles developments at the international and US levels are sparking fresh warnings about the disease, along with renewed efforts to get children vaccinated, according to several recent reports.

May 18, 2011

May 18, 2011

Experts: Regulatory issues are main reason for keeping smallpox virus

(CIDRAP News) – When the World Health Assembly (WHA) considers the fate of the remaining stocks of smallpox virus this week, the debate is likely to be framed in part by a report from a group of independent experts that says the only strong reason for keeping the virus is to satisfy strict regulatory requirements for new vaccines and antivirals.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»